Evolving viral threats
vol.24 iss.1 (2026) pp.2
Harnessing the microbiome for cancer therapy.
(2026)
Keystone concept revisited: insights into microbial community dynamics and control.
(2026)
Chemical whispers hidden in the plant and microbiota kingdoms.
(2026)
The gut microbiome in solid-organ and haematopoietic-stem-cell transplantation.
(2026)
Phage-host dynamics in space.
(2026)
Tree bark microbiota in climate-active gas cycling.
(2026)
Flipping the drug resistance switch.
(2026)
Panning for gold: incidentally sequenced DNA.
(2026)
Tick-borne viruses: discovery, clinical aspects, influencing factors and control.
(2026)
Oral-gut bacterial transport drives chronic liver disease.
(2026)
Overcoming research challenges in resource-limited settings: perspectives from Thailand.
vol.23 iss.3 (2025)
Opposing forces.
vol.23 iss.3 (2025)
Stopping Marburg virus in its tracks.
vol.23 iss.3 (2025)
Microbial interactions lead to ecosystem function.
vol.23 iss.3 (2025)
Mining microbiomes for microproteins.
vol.23 iss.3 (2025)
Anthropogenic impacts on the terrestrial subsurface biosphere.
vol.23 iss.3 (2025)
Akkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential.
vol.23 iss.3 (2025)
Towards next-generation treatment options to combat Plasmodium falciparum malaria.
vol.23 iss.3 (2025)
Examining the healthy human microbiome concept.
vol.23 iss.3 (2025)
Author Correction: Examining the healthy human microbiome concept.
vol.23 iss.3 (2025)
Metagenomics for drug discovery.
vol.23 iss.2 (2025)
Campylobacter spreads colorectal cancer.
vol.23 iss.2 (2025)
Responding to extreme climates.
vol.23 iss.2 (2025)
Linking innate immune evasion to pandemic potential.
vol.23 iss.2 (2025)
Methanogens implicated by DNA evidence.
vol.23 iss.2 (2025)
Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics.
vol.23 iss.2 (2025)
Microbial extracellular polymeric substances in the environment, technology and medicine.
vol.23 iss.2 (2025)
Bacterial small molecule metabolites implicated in gastrointestinal cancer development.
vol.23 iss.2 (2025)
Diversity and ecology of microbial sulfur metabolism.
vol.23 iss.2 (2025)
Microbial solutions must be deployed against climate catastrophe.
vol.23 iss.1 (2025)
Gender justice and prioritizing women and girls in the HIV response.
vol.23 iss.1 (2025)
In tandem towards resistance.
vol.23 iss.1 (2025)
Gut microbiota clocks in stress.
vol.23 iss.1 (2025)
Waning resistance.
vol.23 iss.1 (2025)
A river of resistant genes uncovered by metagenomics.
vol.23 iss.1 (2025)
Harnessing the plant microbiome for sustainable crop production.
vol.23 iss.1 (2025)
Bacterial siderophores: diversity, uptake pathways and applications.
vol.23 iss.1 (2025)
Terrabacteria: redefining bacterial envelope diversity, biogenesis and evolution.
vol.23 iss.1 (2025)
Towards improved biofilm models.
vol.23 iss.1 (2025)
The role of bacterial metabolism in antimicrobial resistance.
(2025)
Settling with the motion.
(2025)
Self-sacrificing cell death to thwart phage infection.
(2025)
The intruders that stole the master key.
(2025)
RNA evolution shapes SARS-CoV-2 success.
(2025)
A gut microbiome-restoring diet.
(2025)
Fungal biofilms in human health and disease.
(2025)
Microbial secondary metabolites: advancements to accelerate discovery towards application.
(2025)
Norovirus replication, host interactions and vaccine advances.
(2025)
Microbiota-neuroepithelial signalling across the gut-brain axis.
(2025)